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Aim.Toevaluatewhetherbodyfatdistribution,birthweight,andfamilyhistoryfordiabetes(FHD)wereassociatedwithmetabolic
syndrome (MetS) in children and adolescents. Methods. A total of 439 Italian obese children and adolescents (5–18 years)
were enrolled. Subjects were divided into 2 groups: prepubertal and pubertal. MetS was diagnosed according to the adapted
National Cholesterol Education Program criteria. Birth weight percentile, central obesity index (measured by dual-energy X-
ray absorptiometry), insulin sensitivity (ISI), and disposition index were evaluated. Multivariate logistic regression models were
used to determine variables associated with MetS. Results. The prevalence of MetS was 17%, with higher percentage in adolescents
than in children (21 versus 12%). In the overall population, central obesity index was a stronger predictor of MetS than insulin
sensitivity and low birth weight. When the two groups were considered, central fat depot remained the strongest predictor of
MetS, with ISI similarly inﬂuencing the probability of MetS in the two groups and birth weight being negatively associated to MetS
only in pubertal individuals. Neither FHD nor degree of fatness was a signiﬁcant predictor of MetS. Conclusion. Simple clinical
parameters like increased abdominal adiposity and low birth weight could be useful tools to identify European obese adolescents
at risk for metabolic complications.
1.Introduction
In Western countries, the prevalence of paediatric obesity
and comorbidities, which cluster together in the metabolic
syndrome (MetS) [1], is going to reach epidemic propor-
tions.DatafromtheNationalHeartLungandBloodInstitute
Lipid Research Clinics and the Princeton Prevalence Study
(1973–1976) and Princeton Follow-up Study (2000–2004)
show that MetS in 5- to 19-year olds represents a risk factor
for cardiovascular disease in adulthood [2]. This ﬁnding
highlights the importance of early recognition of MetS
in obese children as a strategy for primary prevention of
cardiovascular disease later in life.
Clinical studies have shown that low birth weight
increases the risk of MetS in adulthood [3]. The association
betweenbirthweightandMetSinchildhoodisfartobeclear,
and results are controversial, with studies showing a strong
[4–6]o raw e a k[ 7–9] association between low or high birth
weight and MetS.
Moreover, several reports indicate that family history of
diabetes and increased abdominal fat adiposity are strong
risk factors for MetS since childhood [5, 10–13].2 International Journal of Hypertension
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Figure 1: Prevalence of metabolic syndrome according to birth
weight categories SGA, AGA, and LGA denoting small, appropriate,
and large birth weight individuals, respectively. Symbols refer to
comparison (Chi-square test) of prevalence of metabolic syndrome
among birth weight categories, in the whole population, prepuber-
tal subjects, and pubertal subjects. ∗P<. 05
Additionally, the marked decrease of insulin sensitivity
associated with the onset of puberty in growing individuals
[14, 15] may act as a further risk factor for the development
of metabolic comorbidities, particularly in obese subjects.
It is not clear if onset of puberty and its progression
are characterized by diﬀerent determinants of MetS in
adolescents, compared to children.
The aim of the study was to evaluate whether family
history of type 2 diabetes (FHD) in ﬁrst-degree relatives,
either low or high birth weight, and increased central body
fat depot are independent risk factors for the development of
MetS in Italian obese children and adolescents.
2. Methods
2.1. Study Population. The children who participated in the
present cross-sectional investigation are a subsample of an
ongoing longitudinal study exploring risk factors for the
development of type 2 diabetes in young Italian subjects.
Obese children and adolescents, referred to the Endo-
crinology and Diabetes Unit of Bambino Ges` u Children’s
Hospital for obesity from January 2003 to January 2010,
were included in the present investigation if they met the
following criteria: (1) being overweight or obese according
to the International Obesity Task Force [16]; (2) absence
of underlying diseases; (3) Italian origin (all four grand-
parents of Italian descent); (4) availability of data relative
to gestation, birth, and FHD among ﬁrst-degree relatives.
Moreover, as we were interested in the role of fetal factor
in the development of metabolic comorbidities [17], low
and high birth weights (as deﬁned below) were additional
selection factors. Participants were not following a weight-
reducing diet, taking any medication, or carrying a previous
clinical diagnosis known to inﬂuence body composition,
glucose metabolism, physical activity, or dietary intake.
Information on birth weight, FHD, and gestational dia-
betes was obtained. Birth weight was based on information
recorded at the time of birth. The gestational age was deter-
mined by ultrasound in the ﬁrst trimester, if available, and
otherwise calculated from the date of the last menstruation.
Weight at birth was converted into percentiles for gestational
age and sex, according to the Italian birth weight curves
[18]. Participants were deﬁned on the basis of their birth
weight percentile as small for gestational age (SGA) (birth
weight ≤10th percentile), appropriate for gestational age
(AGA) (birth weight >10th and <90th percentile), and large
for gestational age (LGA) (birth weight ≥90th percentile).
FHD was deﬁned by the presence of type 2 diabetes in at
least one parent. FHD, maternal gestational, and pre-existing
diabetes were ascertained by a self-administered parents’
questionnaire.
Writteninformedconsentandassentwereobtainedfrom
parents before any testing procedure. Approval of the pro-
tocol was obtained by the Local Scientiﬁc Committee. The
study was conducted in accordance with The Declaration of
Helsinki.
Aftera12-hourovernightfast,atapproximately8:00Am,
all subjects were admitted in the clinic for one-day inpatient
visit. Height was measured without shoes to the nearest
0.1cm using a wall Stadiometer, and weight was measured in
underweartothenearest0.1kgusingamedicalbalancebeam
scale. To compare body mass index (BMI) across diﬀerent
ages and between genders, values of BMI were expressed as
standard deviation score (SDS) [16]. Blood pressure (BP)
was measured using a standard mercury sphygmomanome-
ter two times in the supine position, at the beginning and
at the end of the visit, using the right arm after the subject
had rested quietly for 5 minutes. On each occasion, three
readings of blood pressure were obtained, and the average
was recorded. Physical maturation was assessed on the basis
of breast development in girls and genitalia development
in boys according to Tanner [19]. Due to the well-known
relationship between pubertal development and decrease in
insulin sensitivity [14, 15], subjects were divided into two
groups according to the pubertal stage: prepubertal (Tanner
stage 1), pubertal (Tanner stage from 2 to 5).
2.2. Metabolic Evaluation. Fasting blood samples were taken
via antecubital vein catheter for measurement of glucose,
insulin, C peptide, high density lipoprotein (HDL), choles-
t e r o l ,a n dt r i g l y c e r i d e s .T h e ns u b j e c t si n g e s t e d1 . 7 5 go f
glucosesolutionperkilogramofbodyweight(toamaximum
of 75g). Plasma samples were drawn for determination
of glucose, insulin, and C peptide concentration every 30
minutes, until 2 hours after glucose load.
Insulin sensitivity index (ISI) [20] was calculated from
oralglucosetolerancetest(OGTT).Ithasbeendemonstrated
to strongly correlate with the euglycemic-hyperinsulinemic
clamp in obese children and adolescents [21].International Journal of Hypertension 3
To asses beta cell function, we used the insulinogenic
index, calculated as the ratio of the increment in the plasma
C peptide level to that in the plasma glucose level during the
ﬁrst 30 minutes after the ingestion of glucose.
The disposition index (DI) [22] was deﬁned as the prod-
uct of ISI and insulinogenic index. It reﬂects the capacity of
pancreatic islets to compensate for lower insulin sensitivity.
2.3. Body Composition Evaluation. At least 10 days after the
ﬁrst inpatient visit children were admitted again for body
composition evaluation. Body composition was measured
by dual-energy X-ray absorptiometry (DEXA) using Hologic
QDR Delphi (Hologic Inc., Bedford, MA), as previously
described [15]. Fat and lean mass were corrected for
diﬀerences in height as follow fat mass/height2 (fat BMI) and
lean mass/height2 (lean BMI), expressed as kg/m2 [23]. Body
fat distribution was evaluated by the central obesity index
calculated as the ratio of the amount of fat tissue in the trunk
region to the amount of fat tissue in the leg region [24].
2.4. Deﬁnition of Metabolic Syndrome. Identiﬁcation of MetS
among children was based on the adult criteria deﬁned
by the National Cholesterol Education Program [1]. In the
adult deﬁnition, a minimum of three of ﬁve major criteria
(obesity determined by waist circumference, hypertension,
low HDL cholesterol levels, elevated triglycerides, and glu-
cose intolerance) should be fulﬁlled. These criteria have
been modiﬁed for children [6]. Overweight and obesity
were deﬁned according to the Obesity Task Force [16]:
hypertriglyceridaemia as triglycerides >95th percentile for
ageandsex[25];lowHDLcholesterolasconcentrations<5th
percentile for age and sex [25]; elevated BP as systolic or
diastolicBP>95thforageandsex[26];glucoseintoleranceas
fasting glucose ≥100mg/dL and/or 2-hour post-OGTT glu-
cose ≥140 [27]. Therefore, we deﬁned MetS as the presence
of at least 2 other ﬁndings out of overweight/obesity.
2.5. Assays. Serum insulin and C peptide were measured
by chemiluminescence on ADVIA Centaur analyzer (Kyowa,
Medex Co., Tokyo, Japan); both assays are two-site sandwich
immunoassays using direct chemiluminescent technology
[intra- and interassay coeﬃcient of variation (CV) 3.3–4.6
and 2.6–5.9%; 3.7–4.1 and 1.0–3.3%, resp.].
Quantitative determination of blood glucose, HDL
cholesterol, and triglycerides was measured by enzymatic
method on Roche automated clinical chemistry analyser
(Roche/Hitachi904analyzer,RocheDiagnostics,Mannheim,
Germany).
Intra- and interassay, CV for glucose, HDL cholesterol,
and triglycerides were 0.9 and 1.8%; 0.6–0.95 and 1.2-1.3%;
1.5% and 1.8%, respectively.
2.6. Statistical Analysis. N u m e r i c a lv a l u e sa r er e p o r t e da s
mean ± standard deviation and categorical variables as
proportions. The Kolmogorov-Smirnov goodness-of-ﬁt test
was used for determining whether sample data are likely
to derive from a normal distributed population. Variables
that diverged signiﬁcantly from normal distribution were
logarithmically transformed before analysis.
Between-group diﬀerences were examined using inde-
pendent sample t-test and Chi-square test for numerical and
categorical variables, respectively.
First, bivariate logistic regression was used to determine
the associations between MetS and gender, age, FHD,
diabetesduringpregnancy,birthweightpercentile,BMISDS,
fat and lean BMI, central obesity index, ISI, insulinogenic
index, and DI. Then, variables signiﬁcantly associated with
MetS were inserted into multivariate logistic regression
analyses,withMetSasdependentvariable.Weperformedthe
multivariate logistic regression analysis in successive steps. In
theﬁrststep,variablesinﬂuencingMetSwereevaluatedinthe
overall population. In the second step, the population was
stratiﬁed according to the pubertal development.
Signiﬁcance level for all tests was set at P<. 05. SPSS
software version 13.0 (SPSS Inc., Chicago, IL) was used for
all analyses.
3. Results
Study participants included 439 obese subjects (213 boys,
226 girls), aging 5.2–17.9 years (mean age 11.3 ± 2.6) with
a mean BMI SDS of 2.2 ± 0.3. Twohundred and one subjects
were prepubertal and 238 were pubertal.
MetS was present in 17.1% of individuals with higher
prevalence in pubertal than prepubertal subjects (21.4 versus
11.9%, P = .008).
Clinical and metabolic characteristics of subjects with
and without MetS, divided according to pubertal develop-
ment, are reported in Table 1.
Girls and boys were equally distributed among individ-
uals with and without MetS in both groups. Surprisingly,
rates of FHD were similar between subjects with and without
MetS. As expected ISI and central obesity index were
signiﬁcantly diﬀerent, with subjects with MetS being more
insulin resistant (prepubertal: 3.0 ± 1.9 versus 4.1 ± 2.3,
P = .010; pubertal: 2.5 ± 1.9 versus 3.6 ± 2.5, P<. 0001)
and having more central fat depot (prepubertal: 1.32 ± 0.20
versus 1.19 ± 0.39, P = .017; pubertal: 1.30 ± 0.29 versus
1.19 ± 0.24, P = .024) compared to individuals without
MetS. Mean birth weight percentile and DI were lower
in individuals with MetS compared to individuals without
MetS, but diﬀerences were statistically signiﬁcant only in the
pubertal group (birth weight percentile prepubertal: 38.2 ±
34.0 versus47.0 ±32.2, P = .117; pubertal33.5 ±30.7 versus
45.0 ± 31.8, P = .011; DI prepubertal: 0.36 ± 0.22 versus
0.46 ± 0.38, P = .204; pubertal: 0.33 ± 0.31 versus 0.41 ±
0.28, P = .012).
3.1. Role of Birth Weight. To further analyze the relation
between birth weight and MetS, we evaluated the prevalence
of MetS into the three birth weight categories. Because low
and high birth weights were selection factors, we had 22.3%
of SGA (n = 98), 62.2% of AGA (n = 273), and 15.5% of
LGA (n = 68).4 International Journal of Hypertension
Table 1: Clinical and metabolic characteristics of obese children and adolescents.
Prepubertal (n.201) Pubertal (n.238)
MetS No MetS P MetS No MetS P
Number 24 177 51 187
Male/female 10/14 92/85 .343 23/28 88/99 .804
Age (years) 9.4 ±1.19 .3 ±1.7 .763 13.2 ±1.91 3 .1 ±2.0 .835
Family history of diabetes (%) 15.0 20.5 .397 7.7 13.3 .399
Birth weight (kg) 3.1 ±0.73 .3 ±0.7 .362 3.2 ±0.63 .3 ±0.6 .098
Birth weight (percentile) 38.2 ±34.04 7 .0 ±32.2 .117 33.5 ±30.74 5 .0 ±31.8 .011
BMI (kg/m2)2 8 .5 ±3.92 7 .8 ±3.6 .379 32.7 ±5.93 1 .4 ±4.9 .115
BMI SDS 2.3 ±0.32 .3 ±0.3 .845 2.3 ±0.32 .2 ±0.3 .077
Fat BMI (kg/m2)1 1 .7 ±2.71 1 .4 ±2.3 .531 12.2 ±3.51 2 .3 ±3.1 .717
Lean BMI (kg/m2)1 5 .7 ±1.51 5 .2 ±1.5 .182 18.2 ±2.71 7 .6 ±2.4 .613
Central obesity index 1.32 ±0.20 1.19 ±0.39 .017 1.30 ±0.29 1.19 ±0.24 .024
HDL cholesterol (mg/dL) 35.7 ±6.54 9 .3 ±9.6 <.0001 37.0 ±6.84 6 .0 ±8.9 <.0001
Triglycerides (mg/dL) 141.1 ±45.67 8 .3 ±38.6 <.0001 177.5 ±93.08 2 .3 ±40.3 <.0001
PAs (mmHg) 107.1 ±12.0 106.9 ±9.6 .961 124.2 ±14.3 114.9 ±12.8 <.0001
PAd (mmHg) 67.9 ±8.46 6 .9 ±9.7 .916 72.1 ±12.16 9 .3 ±10.0 .139
Fasting glucose (mg/dL) 83.3 ±9.48 0 .1 ±6.3 .046 83.4 ±11.88 1 .4 ±7.6 .192
2-hour glucose (mg/dL) 113.2 ±32.1 108.2 ±16.2 .671 125.7 ±23.3 110.5 ±20.4 <.0001
ISI 3.0 ±1.94 .1 ±2.3 .010 2.5 ±1.93 .6 ±2.5 <.0001
Insulinogenic index(C peptide 30−0) 0.13 ±0.06 0.11 ±0.07 .094 0.27 ±0.98 0.13 ± 0.14 .199
DI(C peptide 30−0) 0.36 ±0.22 0.46 ±0.38 .204 0.33 ±0.31 0.41 ± 0.28 .012
MetS, BMI, PAs, PAd, ISI, and DI denote metabolic syndrome, body mass index, systolic blood pressure, diastolic blood pressure, insulin sensitivity index,
and disposition index, respectively.
Table 2: Variables signiﬁcantly associated to metabolic syndrome.
Dependent variable: MetS
Independent variablesa Betab± SE P
Entire population
Log central obesity index 2.815 ±0.947 .003
Log ISI −1.257 ±0.306 <.001
Log birth weight −0.411 ±0.128 .001
Prepubertal group
Log central obesity index 4.804 ±1.587 .002
Log ISI −1.1290.564 .045
Pubertal group
Log central obesity index 2.491 ±1.170 .033
Log ISI −1.013 ±0.371 .006
Log birth weight −0.3850.167 .021
aAll values are log-transformed to approximate normal distribution.
bGeneralized equation estimation method regression coeﬃcient.
MetS and ISI denote metabolic syndrome and insulin sensitivity index,
respectively.
Prevalence of subjects with MetS was signiﬁcantly higher
in the SGA category (25.7%), with LGA having the lowest
(11.8%) and AGA the intermediate (14.5%) prevalence (P =
.015). This trend was maintained in the pubertal group (P =
.027) but not in the prepubertal one (P = .423) (Figure 1).
As gestational diabetes is associated with large size
at birth and is known to strongly inﬂuence the risk of
developing MetS in the oﬀspring [6, 28], we evaluated
theprevalenceofMetSinthediﬀerentbirthweightcategories
after excluding oﬀspring of diabetic mothers. Diabetes
during pregnancy (either gestational diabetes or pre-existing
type 1 or 2 diabetes) was present in 28 cases (6.3%). Most
cases of oﬀspring of diabetic mothers were in the LGA group
(18 out of 28). Prevalence of MetS in the diﬀerent birth
weight categories, after excluding oﬀspring of mother with
diabetes during pregnancy, did not change substantially (in
the whole population 26.1, 13.7, and 10.9% in SGA, AGA,
and LGA, resp., P = .007).
3.2. Logistic Regression Analysis. Bivariate logistic regression
analysis revealed age, lean BMI, insulinogenic index, and
central obesity index to be positively associated with MetS
(P = .033, .004, .027, and .001, resp.) and birth weight, ISI,
and DI to be negatively associated with MetS (P = .003,
<. 001, and = .002, resp.). Gender, FHD, diabetes during
pregnancy, and degree of obesity expressed either as BMI
SDS or fat BMI did not inﬂuence the dependent variable.
In the entire population, the multivariate logistic regres-
sion analysis revealed central obesity index to be positively
and independently associated with MetS and ISI and birth
weight to be negatively associated with MetS, with cen-
tral obesity index being the strongest predictor of MetS
(Table 2).
When the prepubertal and pubertal subjects were anal-
ysed separately, central obesity index remained the most
powerful variable inﬂuencing MetS in both groups, with ISI
similarly inﬂuencing MetS in the two populations and birthInternational Journal of Hypertension 5
weight being negatively associated to MetS only in pubertal
individuals (Table 2).
4. Discussion
In the present study of Italian growing obese individuals,
our ﬁndings revealed that increased central fat depot is
the strongest determinant of MetS, no matter if subjects
were children or adolescents, with central obesity index
being more predictive of MetS than insulin sensitivity.
M o r e o v e r ,l o wb i r t hw e i g h ta p p e a r e dt ob eal e s sp o w e r f u l
risk factor for MetS with signiﬁcant association only in
pubertal individuals. Surprisingly, FHD, age, insulinogenic
index, DI, and degree of obesity, expressed either as BMI
SDS or total fat amount, were not signiﬁcant determinants
of MetS in this cohort of obese subjects.
The central role of abdominal adiposity and particularly
of visceral adiposity in the development of MetS has been
widely demonstrated in adulthood [29, 30]. Similar ﬁndings
have been described in children, where waist circumference
and increased visceral fat depot have been conﬁrmed to be
strong and independent predictors of metabolic alterations
[12, 13]. In the present study, by directly measuring with
the DEXA technique the total fat amount and the body
fat distribution, we showed that in, obese Italian growing
subjects, the preponderance of fat in the abdomen is the real
determinant of MetS, rather than the total body fat amount.
As a matter of fact,neither BMI SDS nor fat BMI appeared to
be risk factors for MetS. Similar ﬁndings were reported by an
Italianstudy,wherewaist-to-heightratiowastheonlyclinical
parameter directly related to MetS, with the same predictive
power of insulin resistance [31].
In our study, SGA individuals showed a signiﬁcant
higherincidenceofMetS,withsubjectsbornLGAapparently
protected from the development of MetS. However, small
size at birth was not an important predictor of MetS as
was central obesity index. The present data of increased
metabolic risk in subjects born SGA conﬁrm a large body
of the literature in adulthood and also in childhood [3].
Moreover, our ﬁndings on apparently protective role of large
size at birth are in contrast with other studies conducted in
diﬀerent ethnic groups, like Pima Indians [28]a n dM e x i c a n
children[5],thathaveshowedanincreasedriskformetabolic
alterations in children born LGA.
We have previously showed that obese children and
adolescents born SGA manifest reduced insulin secretion
in the context of increased insulin resistance milieu and
more evident central repartition of fat than AGA and LGA,
with LGA presenting the highest insulinogenic index, despite
comparable degree of insulin resistance [17]. Similar to
our ﬁndings, a study conducted in French obese children
has showed a favourable metabolic proﬁle in children born
LGA, with obese children and adolescents born with high
birth weight displaying approximately 60% higher insulin
sensitivity and lower central fat distribution compared with
those born eutrophic [9]. One could hypothesize that the
role of large size at birth is diﬀerent in the diﬀerent ethnic
groups, with European obese children being protected from
metabolic complications if born LGA.
As the Pima Indian study has showed that the increased
risk of metabolic alterations among Pima with high birth
weight was largely explained by maternal diabetes during
pregnancy [28], we evaluated the role of diabetes during
pregnancy in our sample of obese children and adolescents.
We found no association with diabetes during pregnancy,
probably because cases of either gestational diabetes or pre-
existing type 1 or 2 diabetes were only 28 and we had no
statistical power to show any relation with MetS.
Surprisingly, FHD was not associated with MetS. Dif-
ferent ﬁndings have been reported by other authors, who
described FHD to be a risk factor for MetS [5] and hyperin-
sulinemia [6] in children and adolescents. One explanation
for this discrepancy could be due to the fact that type 2
diabetes in adults is age dependent. Additionally, we did not
measure directly blood glucose in the parents. It is likely
that in our study some currently healthy parents have silent
diabetesorwilldevelopdiabetesinthefuture.Thiscouldbea
potential source of bias in the classiﬁcation of positive FHD.
The speciﬁc role of FHD in the development of MetS could
not be determined with certainty, and follow-up studies are
needed to conﬁrm our results.
Although our study has strengths, including the use
of imaging technique to evaluate body fat portioning and
a large representative sample of exclusively Italian obese
children and adolescents, we acknowledge some limitations.
First, we did not distinguish visceral from subcutaneous
abdominal fat; secondly, we did not study insulin sensitivity
with the gold standard hyperinsulinaemic euglycemic clamp
technique for its complexity in pediatric patients; thirdly,
because this was a cross-sectional analysis, causation could
not be inferred.
In conclusion, simple clinical parameters like increased
abdominal adiposity, eventually estimated by waist circum-
ferenceandlow birthweight, couldbe usefultools toidentify
obese growing European individuals at risk for metabolic
complications.
As not all obese adults display the clustering of metabolic
and cardiovascular risk factors, with some of them being
metabolically healthy but obese individuals [32], one could
speculate that obese adolescents born LGA, with predom-
inantly peripheral fat portioning, could be healthy obese
adolescents, having a favourable metabolic proﬁle.
Prospective studies with serial measurements of cardio-
vascular risk factors are needed to conﬁrm our ﬁndings.
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